Search for a command to run...
Promoter and Institution shareholding in Thyrocare has decreased year-over-year, diverging from sector averages, which remained stable with no changes.
Public shareholding also reflects a slight decline, indicating a lack of retail confidence amidst overall sector stability.
The best performer in the sector, AGARWALEYE, saw a significant institutional increase, contrasting with Thyrocare's decline, reinforcing the broad-based selling theme.
| Category | Trend | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|
1Promoter Holdings | 71.11% | 71.11% | 71.11% | 71.11% | 71.06% | 71.06% | 71.06% | 71.06% | |
2Public Holdings | 11.65% | 11.11% | 11.5% | 12.16% | 11.5% | 11.56% | 11.17% | 10.62% | |
3Foreign Investors | 3.35% | 2.9% | 2.49% | 1.93% | 2.77% | 2.41% | 3.23% | 4.85% | |
4Domestic Investors | 13.89% | 14.88% | 14.9% | 14.8% | 14.67% | 14.97% | 14.54% | 13.47% |